259 related articles for article (PubMed ID: 17339353)
1. CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes.
Harris TH; Mansfield JM; Paulnock DM
Infect Immun; 2007 May; 75(5):2366-73. PubMed ID: 17339353
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis.
Hertz CJ; Mansfield JM
Cell Immunol; 1999 Feb; 192(1):24-32. PubMed ID: 10066343
[TBL] [Abstract][Full Text] [Related]
3. Resistance to the African trypanosomes is IFN-gamma dependent.
Hertz CJ; Filutowicz H; Mansfield JM
J Immunol; 1998 Dec; 161(12):6775-83. PubMed ID: 9862708
[TBL] [Abstract][Full Text] [Related]
4. Genetics of resistance to the African trypanosomes. V. Qualitative and quantitative differences in interferon production among susceptible and resistant mouse strains.
de Gee AL; Sonnenfeld G; Mansfield JM
J Immunol; 1985 Apr; 134(4):2723-6. PubMed ID: 2579155
[TBL] [Abstract][Full Text] [Related]
5. Targeting of immunostimulatory DNA cures experimental visceral leishmaniasis through nitric oxide up-regulation and T cell activation.
Datta N; Mukherjee S; Das L; Das PK
Eur J Immunol; 2003 Jun; 33(6):1508-18. PubMed ID: 12778468
[TBL] [Abstract][Full Text] [Related]
6. Distinct Toll-like receptor signals regulate cerebral parasite load and interferon α/β and tumor necrosis factor α-dependent T-cell infiltration in the brains of Trypanosoma brucei-infected mice.
Amin DN; Vodnala SK; Masocha W; Sun B; Kristensson K; Rottenberg ME
J Infect Dis; 2012 Jan; 205(2):320-32. PubMed ID: 22116836
[TBL] [Abstract][Full Text] [Related]
7. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
Roda JM; Parihar R; Carson WE
J Immunol; 2005 Aug; 175(3):1619-27. PubMed ID: 16034101
[TBL] [Abstract][Full Text] [Related]
8. Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma antibodies alters trypanosome-susceptible mice to a resistant-like phenotype.
Uzonna JE; Kaushik RS; Gordon JR; Tabel H
J Immunol; 1998 Nov; 161(10):5507-15. PubMed ID: 9820527
[TBL] [Abstract][Full Text] [Related]
9. A proposed density-dependent model of long slender to short stumpy transformation in the African trypanosomes.
Seed JR; Black SJ
J Parasitol; 1997 Aug; 83(4):656-62. PubMed ID: 9267408
[TBL] [Abstract][Full Text] [Related]
10. Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response.
Weighardt H; Feterowski C; Veit M; Rump M; Wagner H; Holzmann B
J Immunol; 2000 Oct; 165(8):4537-43. PubMed ID: 11035094
[TBL] [Abstract][Full Text] [Related]
11. The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent.
Drennan MB; Stijlemans B; Van den Abbeele J; Quesniaux VJ; Barkhuizen M; Brombacher F; De Baetselier P; Ryffel B; Magez S
J Immunol; 2005 Aug; 175(4):2501-9. PubMed ID: 16081822
[TBL] [Abstract][Full Text] [Related]
12. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
13. Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.
Wongratanacheewin S; Kespichayawattana W; Intachote P; Pichyangkul S; Sermswan RW; Krieg AM; Sirisinha S
Infect Immun; 2004 Aug; 72(8):4494-502. PubMed ID: 15271908
[TBL] [Abstract][Full Text] [Related]
14. A revised arithmetic model of long slender to short stumpy transformation in the African trypanosomes.
Seed JR; Black SJ
J Parasitol; 1999 Oct; 85(5):850-4. PubMed ID: 10577719
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12p70-dependent interferon- gamma production is crucial for resistance in African trypanosomiasis.
Barkhuizen M; Magez S; Atkinson RA; Brombacher F
J Infect Dis; 2007 Oct; 196(8):1253-60. PubMed ID: 17955445
[TBL] [Abstract][Full Text] [Related]
16. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
[TBL] [Abstract][Full Text] [Related]
17. Distinct modulatory effects of LPS and CpG on IL-18-dependent IFN-gamma synthesis.
Gould MP; Greene JA; Bhoj V; DeVecchio JL; Heinzel FP
J Immunol; 2004 Feb; 172(3):1754-62. PubMed ID: 14734758
[TBL] [Abstract][Full Text] [Related]
18. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration.
Heikenwalder M; Polymenidou M; Junt T; Sigurdson C; Wagner H; Akira S; Zinkernagel R; Aguzzi A
Nat Med; 2004 Feb; 10(2):187-92. PubMed ID: 14745443
[TBL] [Abstract][Full Text] [Related]
19. Experimental African trypanosomiasis: lack of effective CD1d-restricted antigen presentation.
Shi MQ; Wang CR; Wei GJ; Pan WL; Appleyard G; Tabel H
Parasite Immunol; 2006 Dec; 28(12):643-7. PubMed ID: 17096643
[TBL] [Abstract][Full Text] [Related]
20. Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes.
Lopez R; Demick KP; Mansfield JM; Paulnock DM
J Immunol; 2008 Oct; 181(7):4908-17. PubMed ID: 18802094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
